Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A P Fletcher

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
The Biochemical Journal|July 1, 1983
Formation of soluble fibrin oligomers in purified systems and in plasmaN Alkjaersig, A P Fletcher
Thrombosis and Haemostasis|December 15, 1977
The use and monitoring of antithrombotic drug therapy. The need for a new approachA P Fletcher, N Alkjaersig
The Milbank Memorial Fund Quarterly|January 1, 1972
Blood screening methods for the diagnosis of venous thrombosisA P Fletcher, N Alkjaersig
Progress in Hematology|January 1, 1986
The hematologic consequences of thrombolytic therapyA P Fletcher, N K Alkjaersig
Adverse Drug Reactions and Toxicological Reviews|May 29, 2000
Aggression as an adverse drug reactionS C Shaw, A P Fletcher
Adverse Drug Reactions and Toxicological Reviews|January 1, 1991
International monitoring for adverse drug reactions of long latencyA P Fletcher, J P Griffin
The Biochemical Journal|November 1, 1970
Tamm-Horsfall urinary glycoprotein. The chemical compositionA P Fletcher, A Neuberger, W A Ratcliffe
The Biochemical Journal|November 1, 1970
Tamm-Horsfall urinary glycoprotein. The subunit structureA P Fletcher, A Neuberger, W A Ratcliffe
American Journal of Obstetrics and Gynecology|August 1, 1979
The influence of pregnancy upon blood coagulation and plasma fibrinolytic enzyme functionA P Fletcher, N K Alkjaersig, R Burstein
Thrombosis and Haemostasis|December 15, 1977
Reduction of coagulation factor XIII concentration in patients with myocardial infarction, cerebral infarction, and other thromboembolic disordersN Alkjaersig, A P Fletcher, M Lewis, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
The Biochemical Journal|July 1, 1983
Formation of soluble fibrin oligomers in purified systems and in plasmaN Alkjaersig, A P Fletcher
Thrombosis and Haemostasis|December 15, 1977
The use and monitoring of antithrombotic drug therapy. The need for a new approachA P Fletcher, N Alkjaersig
The Milbank Memorial Fund Quarterly|January 1, 1972
Blood screening methods for the diagnosis of venous thrombosisA P Fletcher, N Alkjaersig
Progress in Hematology|January 1, 1986
The hematologic consequences of thrombolytic therapyA P Fletcher, N K Alkjaersig
Adverse Drug Reactions and Toxicological Reviews|May 29, 2000
Aggression as an adverse drug reactionS C Shaw, A P Fletcher
Adverse Drug Reactions and Toxicological Reviews|January 1, 1991
International monitoring for adverse drug reactions of long latencyA P Fletcher, J P Griffin
The Biochemical Journal|November 1, 1970
Tamm-Horsfall urinary glycoprotein. The chemical compositionA P Fletcher, A Neuberger, W A Ratcliffe
The Biochemical Journal|November 1, 1970
Tamm-Horsfall urinary glycoprotein. The subunit structureA P Fletcher, A Neuberger, W A Ratcliffe
American Journal of Obstetrics and Gynecology|August 1, 1979
The influence of pregnancy upon blood coagulation and plasma fibrinolytic enzyme functionA P Fletcher, N K Alkjaersig, R Burstein
Thrombosis and Haemostasis|December 15, 1977
Reduction of coagulation factor XIII concentration in patients with myocardial infarction, cerebral infarction, and other thromboembolic disordersN Alkjaersig, A P Fletcher, M Lewis, et al.
Pageof 6